Construction and characterization of a recombinant vaccinia virus expressing murine intercellular adhesion molecule-1: Induction and potentiation of antitumor responses

Human Gene Therapy

Volumn 8, Issue 7, 1997, Pages 851-860

  Uzendoski, Kerry ^a   Kantor, Judy A ^b   Abrams, Scott I ^b   Schlom, Jeffrey ^b   Hodge, James W ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GENE PRODUCT; INTERCELLULAR ADHESION MOLECULE 1; ONCOLYTIC VIRUS; VIRUS VECTOR;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER THERAPY; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION; GENE THERAPY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOLOGICAL MEMORY; INFLAMMATION; LYMPHOBLAST; LYMPHOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RETROVIRUS; SPLEEN CELL; T LYMPHOCYTE; TUMOR CELL; VACCINIA; VIRUS INFECTIVITY; VIRUS RECOMBINANT;

EID: 0030972813     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.7-851     Document Type: Article

References (23)

1. + T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21. Eur. J. Immunol. 25, 2588-2597.
2. BECKER, J.C., TERMEER, C., SCHMIDT, R.E., and BROCKER, E.B. (1993). Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J. Immunol. 151, 7224-7232.
3. BURNO, D.K., KYPRIANOU, N., SARTOR, W.M., FABIAN, D.F., TURNER, J., VU, T., PATEL, A., TRIMBACH, C., and LEFOR, A.T. (1995). Transfection of a murine fibrosarcoma with intercellular adhesion molecule-1 enhances the response to adoptive immunotherapy. Surgery 118, 237-243; discussion 243-244.
4. CAVALLO, F., MARTIN-FONTECHA, A., BELLONE, M., HELTAI, S., GATTI, E., TORNAGHI, P., FRESCHI, M., FORNI, G., DELLABONA, P., and CASORATI, G. (1995). Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol. 25, 1154-1162.
5. CHEN, L., LINSLEY, P.S., and HELLSTROM, K.E. (1993). Costimulation of T cells for tumor immunity. Immunol. Today 14, 483-436.
6. + T lymphocytes. J. Immunol. 148, 1985-1992.
7. + T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155, 45-57.
8. DUSTIN, M.L., ROTHLEIN, R., BHAN, A.K., DINARELLO, C.A., and SPRINGER, T.A. (1986). Induction by IL 1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137, 245-254.
9. EARL, P.L., and MOSS, B., (1993). Generation of recombinant vaccinia viruses. In: Current Protocols in Molecular Biology, vol. 2, suppl. 21. F.M. Ausubel, R. Brent, R.E. Kingston, D. Moore, J.A. Seidman, J.A. Smith, and K. Struhl, eds. (John Wiley & Sons, New York) pp. 16.17.1-16.18.10.
10. FOX, B.A., SPIESS, P.J., KASID, A., PURI, R., MULE, J.J., WEBER, J.S., and ROSENBERG, S.A. (1990). In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes. J. Biol. Response Mod. 9, 499-511.
11. HODGE, J.W., ABRAMS, S., SCHLOM, J., and KANTOR, J.A. (1994). Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res. 54, 5552-5555.
12. HODGE, J.W., MCLAUGHLIN, J.P., ABRAMS, S.I., SHUPERT, W.L., SCHLOM, J., and KANTOR, J.A. (1995). Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Cancer Res. 55, 3598-3603.
13. HORLEY, K.J., CARPENITO, C., BAKER, B., and TAKEI, F. (1989). Molecular cloning of murine intercellular adhesion molecule (ICAM-1). EMBO J. 8, 2889-2896.
14. JOHNSON, J.G., and JENKINS, M.K. (1993). Accessory cell-derived signals required for T cell activation. Immunol. Res. 12, 48-64.
15. KANTOR, J., IRVINE, K., ABRAMS, S., KAUFMAN, H., DIPIETRO, J., and SCHLOM, J. (1992). Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J. Natl. Cancer Inst. 84, 1084-1091.
16. MILLER, J., KNORR, R., FERRONE, M., HOUDEI, R., CARRON, C.P., and DUSTIN, M.L. (1995). Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J. Exp. Med. 182, 1231-1241.
17. REILLY, P.L., WOSKA, J.R., JR., JEANFAVRE, D.D., MCNALLY, E., ROTHLEIN, R., BORMANN, B.J., REILLY, B.D., MAKRIDES, S.C., FORD, P.J., MARSH, H.C., JR., and MOLD, C. (1995). The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J. Immunol. 155, 529-532.
18. SARTOR, W.M., KYPRIANOU, N., FABIAN, D.F., and LEFOR, A.T. (1995). Enhanced expression of ICAM-1 in a murine fibrosarcoma reduced tumor growth rate. J. Surg. Res. 59, 66-74.
19. SCHIRREN, C.A., VOLPEL, H., HOFFMANN, J.C., HENNING, S.W., QIAO, L., AUTSCHBACH, F., DENGLER, T.J., DOHNER, H., and MEUER, S.C. (1993). Biological response modifiers render tumor cells susceptible to autologous effector mechanisms by influencing adhesion receptors. Leuk. Lymphoma 10, 25-33.
20. + T cells. J. Exp Med. 180, 2125-2135.
21. STAUNTON, D.E., DUSTIN, M.L., ERICKSON, H.P., and SPRINGER, T.A. (1990). The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus [published errata appear in Cell 61, 1157, 1990 and Cell 66,: following 1311, 1991]. Cell 61, 243-254.
22. WEISSMAN, A.M. (1994). Cross-linking membrane proteins. In: Current Protocols in Immunology, vol. 1. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, eds. (John Wiley & Sons, New York) pp. 8.1.5-8.1.9.
23. WINGREN, A.G., EDUARDO, P., VARGA, M., TERJE, K., SJOGREN, H., HEDLUND, G., and DOHLSTEN, M. (1995). T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit. Rev. Immunol. 15, 235-253.